---
figid: PMC7773645__fphar-11-591393-g001
figlink: pmc/articles/PMC7773645/figure/F1/
number: F1
caption: The NLRP3 inflammasome pathway associated with potential blockade sites of
  various pharmacological inhibitors to treat fibrosis. NLRP3 (NOD-, LRR- and pyrin
  domain-containing 3) inflammasome in liver fibsosis could be inhibited by NLRP3
  inflammasome assembly inhibitors andrographolide (4) and oridonin (3, targeting
  the NACHT domain in NLRP3), mitochondrial DNA (mt DNA) de novo synthesis inhibitor
  sweroside (1), P2X purinoceptor 7 (P2X7) inhibitor 25-OCH3-PPD (6), Nrf2 pathway
  promotor quercetin (12) and pelargonidin (18), and platelet-derived growth factor-β
  receptor (PDGF-βR) inhibitor tetramethylpyrazine (25); NLRP3 inflammasome in renal
  fibsosis could be inhibited by nuclear factor (NF)-κB pathway inhibitors artemisinin
  (2), compound K (7), and icariin (17), Nrf2 pathway promotor astaxanthin (27), nicotinamide
  adenine dinucleotide phosphate oxidase 4 (NOX4) inhibitor ginsenoside Rg1 (8), ROS
  production inhibitor dihydroquercetin (13), autophagy activator pterostilbene (20),
  and X-linked inhibitor of apoptosis protein (XIAP) suppressant (22); NLRP3 inflammasome
  in cardiac fibsosis could be inhibited by NLRP3 inflammasome assembly inhibitor
  triptolide (5), CD36 inhibitor cinnamaldehyde (26), and TXNIP suppressant of crude
  extract salvianolates (Sal); NLRP3 inflammasome in pulmonary fibsosis could be inhibited
  by NLRP3 inflammasome assembly inhibitor lycorine (23, targeting the PYD of ASC),
  autophagy activator resveratrol (19), and NF-κB pathway inhibitor polydatin (21);
  NLRP3 inflammasome in synovial tissue fibsosis could be inhibited by hypoxia-inducible
  factors (HIF)-1α pathway inhibitor casticin (14); NLRP3 inflammasome in pancreatic
  fibrosis might be inhibited by autophagy activator saikosaponin A (10).
pmcid: PMC7773645
papertitle: Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis.
reftext: Nan Ding, et al. Front Pharmacol. 2020;11:591393.
pmc_ranked_result_index: '53736'
pathway_score: 0.9469142
filename: fphar-11-591393-g001.jpg
figtitle: NLRP3 inflammasome pathway associated with potential blockade sites of various
  pharmacological inhibitors to treat fibrosis
year: '2020'
organisms:
- Mus musculus
- Rattus norvegicus
- Oreocome striata
- Andrographis paniculata
- Abelmoschus manihot
- Mycoplasmoides pneumoniae
- Salvia miltiorrhiza
- Manulea altissima
- Pseudotsuga menziesii
- Artemisia annua
- Malus domestica
- Narcissus pseudonarcissus
- Pelargonium x hortorum
- Panax ginseng
- Candida dubliniensis
- Panax notoginseng
- Tripterygium wilfordii
- Bupleurum falcatum
- Glycyrrhiza glabra
- Isodon rubescens
- Larix sibirica
- Polygonum cuspidatum
- Homo sapiens
- Bos taurus
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7773645__fphar-11-591393-g001.html
  '@type': Dataset
  description: The NLRP3 inflammasome pathway associated with potential blockade sites
    of various pharmacological inhibitors to treat fibrosis. NLRP3 (NOD-, LRR- and
    pyrin domain-containing 3) inflammasome in liver fibsosis could be inhibited by
    NLRP3 inflammasome assembly inhibitors andrographolide (4) and oridonin (3, targeting
    the NACHT domain in NLRP3), mitochondrial DNA (mt DNA) de novo synthesis inhibitor
    sweroside (1), P2X purinoceptor 7 (P2X7) inhibitor 25-OCH3-PPD (6), Nrf2 pathway
    promotor quercetin (12) and pelargonidin (18), and platelet-derived growth factor-β
    receptor (PDGF-βR) inhibitor tetramethylpyrazine (25); NLRP3 inflammasome in renal
    fibsosis could be inhibited by nuclear factor (NF)-κB pathway inhibitors artemisinin
    (2), compound K (7), and icariin (17), Nrf2 pathway promotor astaxanthin (27),
    nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) inhibitor ginsenoside
    Rg1 (8), ROS production inhibitor dihydroquercetin (13), autophagy activator pterostilbene
    (20), and X-linked inhibitor of apoptosis protein (XIAP) suppressant (22); NLRP3
    inflammasome in cardiac fibsosis could be inhibited by NLRP3 inflammasome assembly
    inhibitor triptolide (5), CD36 inhibitor cinnamaldehyde (26), and TXNIP suppressant
    of crude extract salvianolates (Sal); NLRP3 inflammasome in pulmonary fibsosis
    could be inhibited by NLRP3 inflammasome assembly inhibitor lycorine (23, targeting
    the PYD of ASC), autophagy activator resveratrol (19), and NF-κB pathway inhibitor
    polydatin (21); NLRP3 inflammasome in synovial tissue fibsosis could be inhibited
    by hypoxia-inducible factors (HIF)-1α pathway inhibitor casticin (14); NLRP3 inflammasome
    in pancreatic fibrosis might be inhibited by autophagy activator saikosaponin
    A (10).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRS1
  - NOX4
  - XIAP
  - STAG1
  - AKT2
  - AKT3
  - AKT1
  - NLRP3
  - MNT
  - TXNIP
  - PYCARD
  - MTOR
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - S100A9
  - IL16
  - IL18
  - MMRN1
  - CD36
  - TLR4
  - TLR6
  - NACHT
  - XIAP
genes:
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: NOX4
  symbol: NOX4
  source: hgnc_symbol
  hgnc_symbol: NOX4
  entrez: '50507'
- word: XIAP
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: Sal
  symbol: SA1
  source: hgnc_alias_symbol
  hgnc_symbol: STAG1
  entrez: '10274'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: mnt
  symbol: MNT
  source: hgnc_symbol
  hgnc_symbol: MNT
  entrez: '4335'
- word: TXNIP
  symbol: TXNIP
  source: hgnc_symbol
  hgnc_symbol: TXNIP
  entrez: '10628'
- word: ASC
  symbol: ASC
  source: hgnc_alias_symbol
  hgnc_symbol: PYCARD
  entrez: '29108'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: Nif?
  symbol: NIF
  source: hgnc_alias_symbol
  hgnc_symbol: S100A9
  entrez: '6280'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: IL-16
  symbol: IL-16
  source: hgnc_alias_symbol
  hgnc_symbol: IL16
  entrez: '3603'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: ECM/collagendeposition-
  symbol: ECM
  source: hgnc_alias_symbol
  hgnc_symbol: MMRN1
  entrez: '22915'
- word: ECM/collagen
  symbol: ECM
  source: hgnc_alias_symbol
  hgnc_symbol: MMRN1
  entrez: '22915'
- word: CD36
  symbol: CD36
  source: hgnc_symbol
  hgnc_symbol: CD36
  entrez: '948'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR6
  symbol: TLR6
  source: hgnc_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
chemicals:
- word: NACHT
  source: MESH
  identifier: C416503
diseases:
- word: XIAP
  source: MESH
  identifier: C564469
figid_alias: PMC7773645__F1
redirect_from: /figures/PMC7773645__F1
figtype: Figure
---
